Publicacións en colaboración con investigadores/as de Universidad Complutense de Madrid (22)

2024

  1. Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study

    International Journal of Cardiology, Vol. 401

  2. Prognostic Utility of Society for Cardiovascular Angiography and Interventions Shock Stage Approach for Classifying Cardiogenic Shock Severity in Takotsubo Syndrome

    Journal of the American Heart Association, Vol. 13, Núm. 6, pp. e032951

2023

  1. A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis

    Trends in Cardiovascular Medicine, Vol. 33, Núm. 5, pp. 319-326

  2. Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19

    Journal of Clinical Medicine, Vol. 12, Núm. 11

  3. Heart failure in older patients with atrial fibrillation: incidence and risk factors

    Revista Espanola de Cardiologia

  4. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  5. Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?

    International Journal of Cardiology, Vol. 386, pp. 59-64

  6. Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection

    Life, Vol. 13, Núm. 4

  7. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Frontiers in Endocrinology, Vol. 14

  8. Takotsubo Syndrome, Stressful Triggers, and Risk of Recurrence

    American Journal of Cardiology, Vol. 205, pp. 58-62

2021

  1. Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19

    Age and ageing, Vol. 50, Núm. 2, pp. 326-334

  2. Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry

    Obesity Research and Clinical Practice, Vol. 15, Núm. 3, pp. 275-280

  3. Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes

    Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791

  4. MEESSI-AHF risk score performance to predict multiple post-index event and post-discharge short-term outcomes

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 2, pp. 142-152

  5. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

    Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966

  6. Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry

    American Heart Journal, Vol. 237, pp. 104-115

  7. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

  8. Synergistic Impact of Systolic Blood Pressure and Perfusion Status on Mortality in Acute Heart Failure

    Circulation. Heart failure, Vol. 14, Núm. 3, pp. e007347

  9. Triglycerides and Residual Atherosclerotic Risk

    Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041

  10. Underlying heart diseases and acute covid-19 outcomes

    Cardiology Journal, Vol. 28, Núm. 2, pp. 202-214